Insider · CIK 1723524
Darren Sherman
- Director at Orchestra BioMed Holdings OBIO: 2 buys, 11 sales
- Director at Motus GI Holdings MOTS: 4 buys, 0 sales
Full history from EDGAR: holdings now, every transaction and Form 144 planned sales
Open-market buys6
Open-market sales11
Bought$252K
Sold$634K
Every trade, with what the company filed around it
Open-market buys and sales as each Form 4 states them, newest first.
How these figures work
Notes on each row are as each Form 4 states them, next to SEC Tracker's own records of the company's filings and other insiders' buys. Holding after is what the filing reports they held after the trade, with the change in their holding.
| Date | Company | Trade | Value | Holding after | Notes |
|---|---|---|---|---|---|
| Nov 2, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $5.74 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. | $86K | 1,104,402 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Nov 2, 2026. |
| Oct 1, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $6.36 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. | $95K | 1,119,402 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Oct 1, 2026. |
| Sep 1, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $4.94 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 1, 2026. | $74K | 1,134,402 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Sep 1, 2026. |
| Aug 26, 2026 | Orchestra BioMed Holdings OBIO | Tax withholding 4,925 sh at $5.26 16 days after the company's 10-Q filed Aug 10, 2026. | $26K | 1,149,402 | 16 days after the company's 10-Q filed Aug 10, 2026. |
| Aug 26, 2026 | Orchestra BioMed Holdings OBIO | Bought 2,000 sh at $5.33 Their first shares, by the holdings the Form 4 states. 16 days after the company's 10-Q filed Aug 10, 2026. | $11K | 2,000 | Their first shares, by the holdings the Form 4 states. 16 days after the company's 10-Q filed Aug 10, 2026. |
| Aug 3, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $4.09 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 3, 2026. | $61K | 1,154,327 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Aug 3, 2026. |
| Jul 1, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $4.27 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2026. | $64K | 1,169,327 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jul 1, 2026. |
| Jun 1, 2026 | Orchestra BioMed Holdings OBIO | Sold (10b5-1) 15,000 sh at $3.87 The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. | $58K | 1,184,327 −1% | The filing says this sale was under a Rule 10b5-1 plan set up in advance. The same day as a Form 144 notice of a planned insider sale filed Jun 1, 2026. |
| May 28, 2026 | Orchestra BioMed Holdings OBIO | Tax withholding 4,925 sh at $3.98 16 days after the company's 10-Q filed May 12, 2026. | $20K | 1,199,327 | 16 days after the company's 10-Q filed May 12, 2026. |
| Mar 25, 2026 | Orchestra BioMed Holdings OBIO | Tax withholding 33,317 sh at $4.57 13 days after the company's 10-K filed Mar 12, 2026. | $152K | 1,204,252 | 13 days after the company's 10-K filed Mar 12, 2026. |
| Feb 12, 2026 | Orchestra BioMed Holdings OBIO | Award 397,000 sh 6 days after the company's S-8 filed Feb 6, 2026. | 1,237,569 | 6 days after the company's S-8 filed Feb 6, 2026. | |
| Jan 2, 2026 | Orchestra BioMed Holdings OBIO | Tax withholding 5,588 sh at $4.31 42 days after the company's 424B3 filed Nov 21, 2025. | $24K | 840,569 | 42 days after the company's 424B3 filed Nov 21, 2025. |
| Nov 25, 2025 | Orchestra BioMed Holdings OBIO | Tax withholding 40,340 sh at $5.35 4 days after the company's 424B3 filed Nov 21, 2025. | $216K | 846,157 | 4 days after the company's 424B3 filed Nov 21, 2025. |
| Sep 3, 2025 | Orchestra BioMed Holdings OBIO | Tax withholding 40,340 sh at $2.72 22 days after the company's 10-Q filed Aug 12, 2025. | $110K | 886,497 | 22 days after the company's 10-Q filed Aug 12, 2025. |
| Aug 25, 2025 | Orchestra BioMed Holdings OBIO | Bought 3,000 sh at $2.62 Their first open-market buy here in SEC Tracker's records. One of 3 insiders who bought $83K over 22 days, within the 30-day window. 13 days after the company's 10-Q filed Aug 12, 2025. | $8K | 926,837 +<1% | Their first open-market buy here in SEC Tracker's records. One of 3 insiders who bought $83K over 22 days, within the 30-day window. 13 days after the company's 10-Q filed Aug 12, 2025. |
| Aug 7, 2025 | Orchestra BioMed Holdings OBIO | Award 120,000 sh 1 day after the company's SCHEDULE 13D/A filed Aug 6, 2025. | 923,837 | 1 day after the company's SCHEDULE 13D/A filed Aug 6, 2025. | |
| May 28, 2025 | Orchestra BioMed Holdings OBIO | Tax withholding 45,843 sh at $2.95 28 days after the company's DEFA14A filed Apr 30, 2025. | $135K | 803,837 | 28 days after the company's DEFA14A filed Apr 30, 2025. |
| Apr 4, 2025 | Orchestra BioMed Holdings OBIO | Award 115,708 sh 44 days after the company's S-8 filed Feb 19, 2025. | 849,680 | 44 days after the company's S-8 filed Feb 19, 2025. | |
| Dec 5, 2024 | Orchestra BioMed Holdings OBIO | Tax withholding 31,815 sh at $5.57 168 days after the company's 8-K filed Jun 20, 2024. | $177K | 733,972 | 168 days after the company's 8-K filed Jun 20, 2024. |
| Sep 10, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,904 sh at $5.31 The filing does not mark this sale as under a Rule 10b5-1 plan. 82 days after the company's 8-K filed Jun 20, 2024. | $37K | 765,787 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 82 days after the company's 8-K filed Jun 20, 2024. |
| Sep 9, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,804 sh at $5.48 The filing does not mark this sale as under a Rule 10b5-1 plan. 81 days after the company's 8-K filed Jun 20, 2024. | $37K | 772,691 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 81 days after the company's 8-K filed Jun 20, 2024. |
| Sep 6, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,819 sh at $5.65 The filing does not mark this sale as under a Rule 10b5-1 plan. 78 days after the company's 8-K filed Jun 20, 2024. | $39K | 779,495 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 78 days after the company's 8-K filed Jun 20, 2024. |
| Sep 5, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,961 sh at $5.85 The filing does not mark this sale as under a Rule 10b5-1 plan. 77 days after the company's 8-K filed Jun 20, 2024. | $41K | 786,314 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 77 days after the company's 8-K filed Jun 20, 2024. |
| Sep 4, 2024 | Orchestra BioMed Holdings OBIO | Sold 6,837 sh at $6.10 The filing does not mark this sale as under a Rule 10b5-1 plan. 76 days after the company's 8-K filed Jun 20, 2024. | $42K | 793,275 −1% | The filing does not mark this sale as under a Rule 10b5-1 plan. 76 days after the company's 8-K filed Jun 20, 2024. |
| May 8, 2024 | Orchestra BioMed Holdings OBIO | Award 176,667 sh 8 days after the company's DEF 14A filed Apr 30, 2024. | 800,112 | 8 days after the company's DEF 14A filed Apr 30, 2024. | |
| Jul 20, 2023 | Orchestra BioMed Holdings OBIO | Award 539,667 sh 7 days after the company's 8-K/A filed Jul 13, 2023. | 623,445 | 7 days after the company's 8-K/A filed Jul 13, 2023. | |
| Apr 12, 2023 | Orchestra BioMed Holdings OBIO | Option exercise 14,959 sh at $15.00 9 days after the company's S-8 filed Apr 3, 2023. | $224K | 83,778 | 9 days after the company's S-8 filed Apr 3, 2023. |
| Jan 26, 2023 | Orchestra BioMed Holdings OBIO | Award 68,819 sh | 68,819 | ||
| Jan 26, 2023 | Orchestra BioMed Holdings OBIO | Award 68,189 sh | 68,189 | ||
| Jan 5, 2022 | Motus GI Holdings MOTS | Award 90,521 sh | 194,602 | ||
| Feb 17, 2021 | Motus GI Holdings MOTS | Award 30,000 sh | 81,890 | ||
| Feb 17, 2021 | Motus GI Holdings MOTS | Award 22,191 sh | 104,081 | ||
| Jan 12, 2021 | Motus GI Holdings MOTS | Award 9,144 sh | 51,890 | ||
| Dec 17, 2020 | Motus GI Holdings MOTS | Bought 3,000 sh at $0.97 | $3K | 42,746 +8% | |
| Oct 12, 2020 | Motus GI Holdings MOTS | Award 10,346 sh | 39,746 | ||
| Jul 10, 2020 | Motus GI Holdings MOTS | Award 7,900 sh | 29,400 | ||
| Feb 6, 2020 | Motus GI Holdings MOTS | Award 12,500 sh | 21,500 | ||
| May 31, 2018 | Motus GI Holdings MOTS | Other 1,000,000 sh | 109,792 | ||
| May 31, 2018 | Motus GI Holdings MOTS | Other 2,000,000 sh | 2,000,000 | ||
| May 17, 2018 | Motus GI Holdings MOTS | Bought 1,000 sh at $5.55 | $6K | 9,000 +13% | |
| Feb 16, 2018 | Motus GI Holdings MOTS | Bought 45,000 sh at $5.00 Their first open-market buy here in SEC Tracker's records. One of 3 insiders who bought $810K over 1 day, within the 30-day window. | $225K | Their first open-market buy here in SEC Tracker's records. One of 3 insiders who bought $810K over 1 day, within the 30-day window. | |
| Feb 16, 2018 | Motus GI Holdings MOTS | Conversion 750 sh One of 3 insiders who bought $810K over 1 day, within the 30-day window. | 8,000 | One of 3 insiders who bought $810K over 1 day, within the 30-day window. | |
| Feb 16, 2018 | Motus GI Holdings MOTS | Conversion 99,748 sh One of 3 insiders who bought $810K over 1 day, within the 30-day window. | 1,109,792 | One of 3 insiders who bought $810K over 1 day, within the 30-day window. | |
| Feb 16, 2018 | Motus GI Holdings MOTS | Conversion 65,038 sh One of 3 insiders who bought $810K over 1 day, within the 30-day window. | 1,159,968 | One of 3 insiders who bought $810K over 1 day, within the 30-day window. |
Open-market trades are Form 4 transaction codes P (purchase) and S (sale). Planned sales are those the filing marks as made under a Rule 10b5-1 plan. A P-code buy at the offering price within a day of the company's FWP, 424B prospectus or offering 8-K is marked Bought in the offering and left out of open-market buy counts and cluster buys. Prices and values are as stated in each Form 4. Stock prices aren't shown on this page. Not investment advice.
Data on this page was fetched . The filing on SEC.gov is the record.